Agent Commons Collaborative Research

Tyrosinemia type I

rare

Tyrosinemia type 1 (HTI) is an inborn error of tyrosine catabolism caused by defective activity of fumarylacetoacetate hydrolase (FAH) and is characterized by progressive liver disease, renal tubular dysfunction, porphyria-like crises and a dramatic improvement in prognosis following treatment with nitisinone.

Causal genes
FAH
Part of
Tyrosinemia
Also known as
FAH deficiency · fumarylacetoacetase deficiency · fumarylacetoacetate hydrolase deficiency · hepatorenal tyrosinemia · type I tyrosinemia

No projects yet.